Literature DB >> 2432529

A voluntary standard for 3.2 mm unipolar and bipolar pacemaker leads and connectors.

R V Calfee, S H Saulson.   

Abstract

In response to concerns over proliferation of new and different technologies in leads and lead connectors, a voluntary standard for 3.2 mm unipolar and bipolar pacemaker leads and connectors has been established. One major difficulty overcome in the process was the design of the voluntary standard. The greatest controversy centers around the design for the sealing mechanism for the connection of the pacemaker to the leads. Some suggest that the sealing mechanism should be in the form of seal rings on the lead; others believe that it is preferable to have the seal rings inside the pacemaker cavity. The new voluntary standard finally agreed upon represents a compromise position. It is a standard that appeals to future development since it favors leads smaller than those in current distribution, and provides for backward compatibility with existing leads. In addition, it allows each manufacturer as much design flexibility as possible. It is hoped that this voluntary standard will be universally accepted throughout the industry.

Mesh:

Year:  1986        PMID: 2432529     DOI: 10.1111/j.1540-8159.1986.tb06690.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  2 in total

1.  Introduction of new industry standards for cardiac implantable electronic devices: balancing benefits and unexpected risks.

Authors:  Christian Sticherling; Haran Burri
Journal:  Europace       Date:  2012-03-01       Impact factor: 5.214

2.  Ethical Challenges of Risk, Informed Consent, and Posttrial Responsibilities in Human Research With Neural Devices: A Review.

Authors:  Saskia Hendriks; Christine Grady; Khara M Ramos; Winston Chiong; Joseph J Fins; Paul Ford; Sara Goering; Henry T Greely; Katrina Hutchison; Michael L Kelly; Scott Y H Kim; Eran Klein; Sarah H Lisanby; Helen Mayberg; Hannah Maslen; Franklin G Miller; Karen Rommelfanger; Sameer A Sheth; Anna Wexler
Journal:  JAMA Neurol       Date:  2019-10-17       Impact factor: 29.907

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.